Takeda Pharmaceutical To Release Sustained-Release Morphine Hydrochloride Capsule

Main Category: Cancer / Oncology
Also Included In: Pain / Anesthetics
Article Date: 17 Apr 2006 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:1 star

1 (1 votes)

Healthcare Prof:not yet rated


Tokyo, April, 2006 (JCN) - Takeda Pharmaceutical has launched Passif, its proprietary sustained release capsule of morphine hydrochloride.

Available in three dosages 30mg, 60mg and 120mg, the new agent is indicated for the treatment of pain control for cancer patients with moderate to severe pain. It can exert beneficial effects with a once-a-day dosage.

By Aki Tsukioka, JCN Staff Writer

Company Profile

Copyright © 2006 JCN. All rights reserved. A division of Japan Corporate News Network KK.

Article adapted by Medical News Today from original press release.
Visit our cancer / oncology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Jane Ludlow. "Takeda Pharmaceutical To Release Sustained-Release Morphine Hydrochloride Capsule." Medical News Today. MediLexicon, Intl., 17 Apr. 2006. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/41691.php>

APA
Jane Ludlow. (2006, April 17). "Takeda Pharmaceutical To Release Sustained-Release Morphine Hydrochloride Capsule." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/41691.php.

Please note: If no author information is provided, the source is cited instead.


Cancer / Oncology

What is Cancer?

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Read more...

Most Popular Articles



Follow Our Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cancer / Oncology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »